A surveillance study to evaluate impact of PCV13 on pneumococcal pneumonia with pleural effusions in the 2 years after the use of PCV1
Latest Information Update: 09 Sep 2021
Price :
$35 *
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 09 Sep 2021 New trial record
- 01 Sep 2021 Results published in the Journal of Infectious Diseases